<DOC>
	<DOCNO>NCT00250471</DOCNO>
	<brief_summary>The primary purpose study compare efficacy safety bivalirudin eptifibatide ( without unfractionated heparin enoxaparin ) give subject high risk heart attack cardiovascular complication undergo surgery open block artery heart .</brief_summary>
	<brief_title>PROTECT-TIMI 30 Trial</brief_title>
	<detailed_description>Platelet inhibitor drug</detailed_description>
	<mesh_term>Angina , Unstable</mesh_term>
	<mesh_term>Fibrinolytic Agents</mesh_term>
	<criteria>Chest paing/discomfort occur rest last least 10 minute least one follow highrisk feature : diabetes elevate cardiac protein blood ( indicate acute coronary syndrome ) Be willing able give inform consent uncontrolled hypertension cardiac episode ( heart attack ) within previous 24 hour randomization trial prior heart surgery ( PCI ) within previous 2 week randomize trial electorcardogram ( ECG ) find make Holter monitor ischemia unable read</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2005</verification_date>
	<keyword>GP IIb/IIIa inhibitor</keyword>
	<keyword>eptifibatide</keyword>
	<keyword>Anti-thrombotic agent</keyword>
</DOC>